Hsp90

Hsp90
Name	Hsp90
Caption	Heat shock protein 90
Family	Heat shock proteins
Location	Cytosol, nucleus, endoplasmic reticulum, mitochondria

Hsp90 Hsp90 is a highly conserved molecular chaperone involved in the folding, stabilization, and regulation of a wide range of substrate proteins across eukaryotes and prokaryotes. Discovered in heat shock studies linked to stress responses in Max Perutz-era protein work and later characterized in biochemical programs involving groups at Cold Spring Harbor Laboratory and the Max Planck Society, Hsp90 integrates signals from signalling hubs such as MAPK pathway, PI3K/AKT pathway, and SRC family kinases to control proteome homeostasis. Its importance in cellular physiology made Hsp90 a focus of translational research at institutions like National Institutes of Health, Dana-Farber Cancer Institute, and pharmaceutical efforts at Pfizer and Novartis.

Structure and isoforms

Hsp90 exists as a ~90 kilodalton homodimer with each protomer organized into N-terminal ATP-binding, middle, and C-terminal dimerization domains, a topology resolved by structural biology teams at European Molecular Biology Laboratory, Harvard University, and Max Planck Institute; cryo-EM, X-ray crystallography, and NMR studies led by groups affiliated with Stanford University and University of Cambridge defined conformational states relevant to function. Multiple isoforms arise from distinct genes and organellar targeting: the cytosolic isoforms encoded by genes studied at Cold Spring Harbor Laboratory and annotated by National Center for Biotechnology Information; the endoplasmic reticulum paralog characterized in work from The Scripps Research Institute; and the mitochondrial TRAP1 family explored in reports from University of California, San Diego and University of Oxford. Post-translational modifications mapped by proteomics teams at European Bioinformatics Institute and Wellcome Trust include phosphorylation sites identified by collaborations between Massachusetts Institute of Technology and University of Tokyo.

Mechanism of chaperone action

Hsp90’s ATPase cycle, elucidated in landmark studies at Yale University and Rockefeller University, couples nucleotide-dependent conformational dynamics to client binding and release in cooperation with co-chaperones characterized at Fred Hutchinson Cancer Research Center and Institut Pasteur. High-resolution structures from groups at ETH Zurich and Columbia University revealed nucleotide-binding pockets targeted by small-molecule inhibitors developed by researchers at Merck and Bristol-Myers Squibb; conformational transitions between open and closed states control client remodeling as shown in biochemical assays from Johns Hopkins University. The chaperone operates within multichaperone assemblies described in collaborative efforts at University of Pennsylvania and Imperial College London, where nucleotide hydrolysis, client transfer, and co-chaperone exchange coordinate proteostasis.

Cellular functions and client proteins

Hsp90 stabilizes and regulates a broad client repertoire including kinases, transcription factors, and steroid hormone receptors defined in screens at Broad Institute and European Molecular Biology Laboratory; representative clients include members of ERBB family, RAF kinases, CDK family, nuclear receptors studied at Yale School of Medicine, and cochaperone-dependent complexes described in work at University College London. Cellular roles mapped by cell biology groups at University of California, San Francisco and Cornell University show Hsp90’s involvement in signal transduction, cell cycle control, and developmental programs probed in model organisms such as Saccharomyces cerevisiae, Drosophila melanogaster, and Caenorhabditis elegans. Proteomic surveys led by teams at Karolinska Institutet and Max Delbrück Center expanded the client list to include factors from DNA damage response machineries and chromatin regulators examined at Cold Spring Harbor Laboratory.

Regulation and co-chaperones

Regulation of Hsp90 activity depends on a conserved set of co-chaperones such as those first biochemically defined at University of Basel and Institute of Cancer Research, including TPR-domain proteins, activating factors, and regulatory adaptors examined at Weizmann Institute of Science and University of Geneva. Co-chaperones like Aha1, p23, Hop, and Cdc37, characterized in studies at University of Chicago and Heidelberg University, modulate ATPase activity, client selection, and assembly dynamics; post-translational modifiers mapped by groups at University of California, Berkeley alter client interactions and subcellular localization. Regulatory networks integrating stress-responsive transcription factors studied at Cold Spring Harbor Laboratory and signaling hubs characterized at Memorial Sloan Kettering Cancer Center coordinate chaperone expression and activity across physiological and pathological contexts.

Role in disease and therapeutic targeting

Dysregulation of Hsp90 function contributes to diseases including oncogenesis, neurodegeneration, and infectious disease as evidenced by translational programs at National Cancer Institute and clinical trials run by consortia involving FDA-regulated investigators and industry partners such as Roche and GSK. Oncogenic clients in pathways involving KRAS, EGFR, and BRAF create Hsp90 dependence exploited by inhibitors developed at Synta Pharmaceuticals and evaluated in studies at MD Anderson Cancer Center; resistance mechanisms and combination strategies have been pursued in collaborative trials with Johns Hopkins University and Vanderbilt University Medical Center. In neurodegenerative disease settings investigated at UCL Queen Square Institute of Neurology and Mayo Clinic, modulation of Hsp90 affects aggregation-prone proteins implicated in Alzheimer's disease, Parkinson's disease, and Huntington's disease, prompting chemical biology efforts at Scripps Research and academic spinouts.

Experimental methods and assays

Experimental interrogation of Hsp90 employs biochemical ATPase assays refined at Cold Spring Harbor Laboratory and EMBL-EBI, structural approaches from European Synchrotron Radiation Facility and Diamond Light Source, and cell-based readouts developed at Broad Institute and Stanford University. Proteomics pipelines at Wellcome Trust Sanger Institute and high-throughput screening platforms at NIH Chemical Genomics Center identify clients and modulators; genetic interaction mapping in model organisms is performed by groups at University of Toronto and University of Cambridge. Methods for monitoring chaperone dynamics include fluorescence resonance energy transfer experiments pioneered at Max Planck Institute for Biophysical Chemistry and single-molecule assays implemented at University of Illinois Urbana-Champaign.

Category:Chaperone proteins